About This Special Issue
With the development of society and the improvement of people's living habits, the incidence of cancer is getting higher and higher all over the world, which is a serious threat to human health. Therefore, it is of great significance to explore economical and convenient obtained markers for early diagnosis, therapeutic efficacy evaluation and prognosis evaluation of tumors.
The primary goal of this special issue is to providing a unique forum for researchers, scholars and practitioners to concern dynamic and rapid evolution of knowledge in the oncology and cancer field. We invite contributions that explore biomarkers associated with tumor diagnosis, treatment efficacy evaluation and prognosis evaluation with particular interest in economical and convenient obtained blood components.
Types of articles welcomed: Original research articles, review articles, case studies, etc.
Through this special issue, we aim to found more convenient methods for clinical cancer treatment and provide new ideas for future basic and clinical researches. We welcome researchers from various disciplines to provide interdisciplinary perspectives on the association of blood components and tumors. Your contributions will play a crucial role in advancing knowledge in this field.
Potential topics include, but are not limited to:
- Blood Cells as Tumor Biomarkers
- Blood Components, such as, Ldh, Alp and so on, as Tumor Markers
- The Association of the Ratio of Blood Components with Tumors
- The Association of the Combination of Blood Components and Traditional Tumor Marker with Tumors
